Agree with you PC that the production figures out of Plutonic are really good. I said yesterday anything around 6700/month would be a win and they have hit 7300/month. Key thing is really about their capital costs and how much of them are one offs and how much are ongoing.
Table 3 shows cash operating cost of $2091/oz and 2321/oz for Plutonic and Henty respectively. So those base costs remain pretty much unchanged at around $15m/month for Plutonic and $5m/month for Henty.
Add royalties and rehab, you get AISC of $2168 and $2477 which is all pretty good.
The AISC gets blown out though with the sustaining capital cost. I'd expect that expenditure to decrease substantially going forward as they did procure a lot of new equipment in the second half of 2023.
It would have been nice for them to give some indication on expected capital costs in Jan-Mar Qtr so we could better assess their likely future performance.
- Forums
- ASX - By Stock
- CYL
- Ann: Quarterly activities report
Ann: Quarterly activities report, page-7
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.01 |
Change
0.015(1.51%) |
Mkt cap ! $222.6M |
Open | High | Low | Value | Volume |
98.0¢ | $1.02 | 98.0¢ | $58.24K | 57.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1117 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 5171 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2417 | 1.005 |
2 | 13317 | 1.000 |
1 | 3000 | 0.995 |
2 | 11889 | 0.990 |
1 | 10000 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.015 | 2971 | 6 |
1.020 | 1434 | 2 |
1.025 | 8392 | 2 |
1.030 | 2950 | 2 |
1.055 | 45695 | 2 |
Last trade - 14.46pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.01 |
  |
Change
0.015 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
$1.01 | $1.02 | $1.00 | 5206 | ||
Last updated 15.07pm 12/06/2024 ? |
Featured News
CYL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online